05/14/2024
11:15 PM | Virpax Pharmaceuticals (Filer)
| Form EFFECT | |
05/13/2024
4:30 PM | Virpax Pharmaceuticals (Filer)
| Form S-1/A | |
05/13/2024
3:02 PM | Virpax Pharmaceuticals (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
05/01/2024
8:54 PM | Virpax Pharmaceuticals (Filer)
| Form S-1/A | |
04/30/2024
6:35 AM | Virpax Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
04/26/2024
4:15 PM | Virpax Pharmaceuticals (Filer)
| Form S-1/A | |
04/18/2024
3:17 PM | Virpax Pharmaceuticals (Filer)
| Form S-1
Registration statement under Securities Act of 1933 | |
|
03/26/2024
7:15 AM | Virpax Pharmaceuticals (Filer)
| Form 10-K
Annual report pursuant to Section 13 or 15(d) | |
03/26/2024
6:30 AM | Virpax Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
03/18/2024
5:30 AM | Virpax Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
03/18/2024
5:30 AM | Virpax Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
03/01/2024
3:05 PM | Virpax Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
01/31/2024
3:22 PM | Floyd Eric (Reporting)
Virpax Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/31/2024
3:22 PM | Bruce Gerald W (Reporting)
Virpax Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/31/2024
3:23 PM | Sendrow Jerrold (Reporting)
Virpax Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/31/2024
3:23 PM | Dubin Michael F (Reporting)
Virpax Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/31/2024
3:24 PM | Mathias Sheila (Reporting)
Virpax Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/31/2024
3:25 PM | Jambulingam Thani (Reporting)
Virpax Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/31/2024
3:25 PM | Shah Vinay (Reporting)
Virpax Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/31/2024
3:26 PM | Singh Vanila (Reporting)
Virpax Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/02/2024
9:11 AM | SABBY MANAGEMENT, LLC (Filed by)
Virpax Pharmaceuticals (Subject)
| Form SC 13G/A | |
12/29/2023
6:30 AM | Virpax Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
12/13/2023
7:30 AM | Virpax Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
12/07/2023
7:58 AM | Virpax Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
12/07/2023
8:08 AM | Virpax Pharmaceuticals (Filer)
| Form DEF 14A | |
12/07/2023
7:50 AM | Virpax Pharmaceuticals (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
11/17/2023
6:30 AM | Virpax Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/17/2023
6:15 AM | Virpax Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/16/2023
3:51 PM | Virpax Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/15/2023
2:03 PM | Virpax Pharmaceuticals (Filer)
| Form NT 10-Q | |
10/11/2023
3:10 PM | Virpax Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
10/03/2023
8:51 AM | Mathias Sheila (Reporting)
Virpax Pharmaceuticals (Issuer)
| Form 3
Initial statement of beneficial ownership of securities | |
09/05/2023
8:28 AM | Virpax Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
08/16/2023
4:00 PM | Shah Vinay (Reporting)
Virpax Pharmaceuticals (Issuer)
| Form 4/A | |
08/16/2023
4:00 PM | Virpax Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
08/14/2023
8:05 AM | Virpax Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
08/14/2023
8:15 AM | Virpax Pharmaceuticals (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
06/22/2023
7:14 AM | Virpax Pharmaceuticals (Filer)
| Form DEFA14A | |
06/21/2023
3:16 PM | Virpax Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
06/21/2023
3:17 PM | Shah Vinay (Reporting)
Virpax Pharmaceuticals (Issuer)
| Form 3
Initial statement of beneficial ownership of securities | |
06/21/2023
3:18 PM | Shah Vinay (Reporting)
Virpax Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
348 million Americans lives to END as we know it? (Ad) 348 million American lives are about to change FOREVER....
Because thanks to one shocking A.I. development I'm revealing for the first time today... To see my free research, simply click here now. |
